Dr. Jason Robert Guertin is a researcher at the Centre de recherche du CHU de Québec – Laval University and an assistant professor in the Department of Preventive and Social Medicine of Université Laval’s Faculty of Medicine.

Financial evaluation is a pivotal component of health technology assessment. It aims to support decision-makers to establish if adopting a novel health technology represents the most efficient use of available resources. Considering that healthcare demands are continuously on the rise, and budgets are overstretched, many health technology assessment units in Canada and abroad are examining the option of reassessing the value of previously adopted technologies using observational economic revaluations. Dr. Guertin’s research program focuses on the various components of economic evaluations and revaluations conducted within an observational setting. More recently, his work has focused on: 1) the development of novel methods aimed at addressing limits associated with observational economic evaluations; 2) evaluating the impact of chronic diseases on patients’ health-related quality of life in Quebec and Canada; and 3) the economic evaluation of health technologies in the field of personalized medicine.

Hôpital Saint-Sacrement
1050 Chemin Sainte-Foy
J1-09B
Québec, QC
Canada G1S 4L8
+1 418-525-4444, extension 82516
jason-robert.guertin@crch... jason.guertin@fmed.ulaval...

Latest news

66 entries « ‹ 2 of 7 › »

Villeneuve T, Trudel X, Gilbert-Ouimet M, Leclerc J, Milot A, Sultan-Taïeb H, Brisson C, Guertin JR

Issue with Evaluating Costs Over Time in a Context of Medical Guideline Changes: An Example in Myocardial Infarction Care Based on a Longitudinal Study from 1997 to 2018

Journal Article

Clinicoecon Outcomes Res, 14 , 2022.

Abstract | Links:

Benasseur I, Talbot D, Durand M, Holbrook A, Matteau A, Potter BJ, Renoux C, Schnitzer ME, Tarride JÉ, Guertin JR

A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases

Journal Article

Pharmacoepidemiol Drug Saf, 31 (4), 2022.

Abstract | Links:

Synodinou D, Savoie-White FH, Sangone A, Chang SL, Beaudoin Cloutier C, Bergeron F, Guertin JR

Health utilities in burn injury survivors: A systematic review

Journal Article

Burns, 48 (1), 2022.

Abstract | Links:

Tadrous M, Shakeri A, Hayes KN, Neville HL, Houlihan J, Clement F, Guertin JR, Law MR, Gomes T

Canadian Trends and Projections in Prescription Drug Purchases: 2001–2023

Journal Article

Canadian journal of health technologies, 1 (11), 2021.

| Links:

Laberge M, Coulibaly LP, Berthelot S, Borges da Silva R, Guertin JR, Strumpf E, Poirier A, Zomahoun HTV, Poder TG

Development and Validation of an Instrument to Measure Health-Related Out-of-Pocket Costs: The Cost for Patients Questionnaire

Journal Article

Value Health, 24 (8), 2021.

Abstract | Links:

Lapointe J, Dorval M, Chiquette J, Joly Y, Guertin JR, Laberge M, Gekas J, Hébert J, Pomey MP, Cruz-Marino T, Touhami O, Blanchet Saint-Pierre A, Gagnon S, Bouchard K, Rhéaume J, Boisvert K, Brousseau C, Castonguay L, Fortier S, Gosselin I, Lachapelle P, Lavoie S, Poirier B, Renaud MC, Ruizmangas MG, Sebastianelli A, Roy S, Côté M, Racine MM, Roy MC, Côté N, Brisson C, Charette N, Faucher V, Leblanc J, Dubeau MÈ, Plante M, Desbiens C, Beaumont M, Simard J, Nabi H

A Collaborative Model to Implement Flexible, Accessible and Efficient Oncogenetic Services for Hereditary Breast and Ovarian Cancer: The C-MOnGene Study

Journal Article

Cancers (Basel), 13 (11), 2021.

Abstract | Links:

Poder TG, Guertin JR, Touré M, Pratte G, Gauvin C, Feeny D, Furlong W, Camden C

Canadian French translation and linguistic validation of the health-related quality of life utility measure for pre-school children

Journal Article

Expert Rev Pharmacoecon Outcomes Res, 21 (6), 2021.

Abstract | Links:

Berthelot S, Breton M, Guertin JR, Archambault PM, Berger Pelletier E, Blouin D, Borgundvaag B, Duhoux A, Harvey Labbe L, Laberge M, Lachapelle P, Lapointe-Shaw L, Layani G, Lefebvre G, Mallet M, Matthews D, McBrien K, McLeod S, Mercier E, Messier A, Moore L, Morris J, Morris K, Ovens H, Pageau P, Paquette JS, Perry J, Schull M, Simon M, Simonyan D, Stelfox HT, Talbot D, Vaillancourt S

A Value-Based Comparison of the Management of Ambulatory Respiratory Diseases in Walk-in Clinics, Primary Care Practices, and Emergency Departments: Protocol for a Multicenter Prospective Cohort Study

Journal Article

JMIR Res Protoc, 10 (2), 2021.

Abstract | Links:

Sinyavskaya L, Schnitzer M, Renoux C, Guertin JR, Talbot D, Durand M

Evidence of the Different Associations of Prognostic Factors With Censoring Across Treatment Groups and Impact on Censoring Weight Model Specification: The Example of Anticoagulation in Atrial Fibrillation

Journal Article

Am J Epidemiol, 190 (12), 2021.

Abstract | Links:

Khalili M, Lepeytre F, Guertin JR, Goupil R, Troyanov S, Bouchard J, Madore F

Impact of updated recommendations on acetylsalicylic acid use for primary prevention of cardiovascular disease in Canada: a population-based survey

Journal Article

CMAJ Open, 8 (1), 2020.

Abstract | Links:

66 entries « ‹ 2 of 7 › »
Signaler des ajouts ou des modifications

Active projects

  • A multicenter skin research group focusing on novel treatment for epidermolysis, from 2022-12-01 to 2023-11-30
  • Adaptation of a standardized self-reported cost questionnaire specific for the severe burn injury population (BI-CoPaQ), from 2022-10-18 to 2023-10-17
  • Coûts des maladies cardiovasculaires et des problèmes de santé mentale attribuables aux contraintes psychosociales au travail : Une étude longitudinale de 22 ans auprès de 9 000 cols blancs., from 2016-07-01 to 2024-03-31
  • Création d’une macro standardisée et validée permettant l’ajustement pour l’inflation des données économiques comprises dans les données médico-administratives, from 2022-08-01 to 2024-03-31
  • Étude de l'éco-efficience du port de l'équipement de protection individuelle contre la COVID-19 dans les urgences pour un contexte post-pandémique, from 2021-10-01 to 2024-03-31
  • Étude préclinique et pharmacoépidémiologique de l’impact du dutastéride dans l’étiopathogenèse et la progression de la maladie de Parkinson, from 2021-04-01 to 2023-08-31
  • Optimisation des approches méthodologiques utilisées dans le cadre d’évaluations économiques basées sur des données observationnelles, from 2019-07-01 to 2023-06-30
  • Optimisation des approches méthodologiques utilisées dans le cadre d’évaluations économiques basées sur des données observationnelles, from 2019-07-01 to 2023-06-30
  • PEGASUS-2 - PErsonalized Genomics for prenatal Abnormalities Screening USing maternal blood : Towards First Tier Screening and Beyond, from 2018-04-01 to 2024-03-31
  • Real World Clinical and Economic Burden of Severe Burn Injuries, from 2023-02-06 to 2025-02-05
  • Reducing low-value practices in acute trauma care: a pragmatic cluster randomized controlled trial, from 2023-04-01 to 2027-03-31
  • Supporting the use of early economic evaluations within the regenerative medicine field, from 2023-04-01 to 2025-01-31
  • The right care, for the right patient, at the right time, by the right provider: A value-based comparison of the management of ambulatory respiratory diseases in walk-in clinics, primary care physician practices and emergency departments, from 2020-04-01 to 2024-03-31
  • The right care, for the right patient, at the right time, by the right provider: A value-based comparison of the management of ambulatory respiratory diseases in walk-in clinics, primary care physician practices and emergency departments, from 2021-10-01 to 2025-03-31

Recently finished projects

  • Audit & Feedback Module Targeting Low-Value Clinical Practices in Injury Care: an Economic Evaluation, from 2020-04-01 to 2023-03-31
  • Canadian Program for Monitoring Overuse in Injury Care, from 2016-07-01 to 2021-06-30
  • Clinical validity and clinical utility of a screening test for Paget's disease of bone, from 2019-03-01 to 2023-03-31
  • How to better manage infectious diseases in ER by triage with molecular mini-panels for the rapid detection of highly transmissible pathogens, from 2018-10-01 to 2022-09-30
  • Infrastructure de l'évaluation économique en médecine régénératrice, from 2020-04-01 to 2023-03-31
  • Pilot study of a community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast, from 2019-10-01 to 2023-03-01
  • Programme de soutien aux nouveaux chercheurs, from 2019-07-01 to 2022-06-30
  • Quand innovations technologique et organisationnelle vont de pair: Un modèle collaboratif pour rendre l'oncogénétique plus agile, accessible et efficiente, from 2020-04-01 to 2022-03-31
  • Real-world effectiveness and cost-effectiveness of novel hepatitis C treatments, from 2020-04-01 to 2022-03-31
  • Real-World Evaluation of the Efficacy, Safety and Cost-Effectiveness of Statins for Primary Prevention of Cardiovascular Disease Among the Elderly – A Causal Perspective to Treatment Trajectory Analysis, from 2019-10-01 to 2023-03-31
  • The right care, for the right patient, at the right time, by the right provider: A value-based comparison of the management of ambulatory respiratory diseases in walk-in clinics, primary care physician practices and emergency departments, from 2021-03-01 to 2022-02-28
Data provided by the Université Laval research projects registery